| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.662 | 0.011 | 0.662 | Aldehyde oxidase inhibitor | |||
| 0.648 | 0.03 | 0.648 | Caspase 9 stimulant | |||
| 0.623 | 0.006 | 0.676 | Superoxide dismutase inhibitor | 0.676 0.005 CID_174699 | CID_174699 | |
| 0.616 | 0.007 | 0.616 | Amyloid beta aggregation inhibitor | 0.248 0.059 CID_174699 | ||
| 0.616 | 0.009 | 0.616 | 5 Hydroxytryptamine release inhibitor | 0.308 0.156 CID_174699 | ||
| 0.601 | 0.01 | 0.601 | Histamine release inhibitor | 0.532 0.02 CID_174699 | ||
| 0.56 | 0.016 | 0.56 | 12-Lipoxygenase inhibitor | |||
| 0.551 | 0.012 | 0.551 | Free radical scavenger | 0.382 0.032 CID_174699 | ||
| 0.566 | 0.029 | 0.566 | 15-Lipoxygenase inhibitor | 0.39 0.079 CID_174699 | ||
| 0.567 | 0.035 | 0.567 | Transcription factor NF kappa B inhibitor | 0.325 0.084 CID_174699 | ||
| 0.541 | 0.014 | 0.541 | Lipoxygenase inhibitor | 0.19 0.151 CID_174699 | ||
| 0.522 | 0.007 | 0.522 | P-glycoprotein inhibitor | 0.203 0.062 CID_174699 | ||
| 0.523 | 0.017 | 0.523 | Caspase 3 stimulant | |||
| 0.561 | 0.058 | 0.561 | Apoptosis agonist | 0.353 0.137 CID_174699 | ||
| 0.519 | 0.018 | 0.519 | Antioxidant | 0.507 0.019 CID_174699 | ||
| 0.508 | 0.007 | 0.508 | Monophenol monooxygenase inhibitor | 0.241 0.025 CID_174699 | ||
| 0.509 | 0.014 | 0.509 | Hypoxia-inducible factor 1 alpha inhibitor | 0.234 0.115 CID_174699 | ||
| 0.543 | 0.068 | 0.543 | Alpha-glucosidase inhibitor | 0.214 0.21 CID_174699 | ||
| 0.465 | 0.008 | 0.465 | Melanin inhibitor | 0.135 0.105 CID_174699 | ||
| 0.452 | 0.007 | 0.452 | 5 Hydroxytryptamine uptake stimulant | 0.192 0.168 CID_174699 | ||
| 0.455 | 0.014 | 0.455 | Peroxidase inhibitor | 0.147 0.08 CID_174699 | ||
| 0.451 | 0.011 | 0.451 | Transcription factor STAT3 inhibitor | |||
| 0.447 | 0.014 | 0.447 | Pyruvate kinase inhibitor | |||
| 0.443 | 0.013 | 0.443 | Transcription factor STAT inhibitor | |||
| 0.462 | 0.037 | 0.462 | Vasodilator, peripheral | |||
| 0.456 | 0.039 | 0.456 | GABA C receptor rho-3 antagonist | |||
| 0.421 | 0.01 | 0.421 | MAO inhibitor | 0.097 0.094 CID_174699 | ||
| 0.426 | 0.025 | 0.426 | Antiamyloidogenic | |||
| 0.423 | 0.033 | 0.423 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.388 | 0.005 | 0.388 | NADPH oxidase inhibitor | |||
| 0.388 | 0.007 | 0.388 | Tumour necrosis factor antagonist | 0.143 0.11 CID_174699 | ||
| 0.39 | 0.01 | 0.39 | Amylase inhibitor | |||
| 0.386 | 0.006 | 0.386 | Neurotrophic factor enhancer | |||
| 0.407 | 0.033 | 0.407 | Vasodilator, coronary | 0.193 0.189 CID_174699 | ||
| 0.375 | 0.005 | 0.439 | Breast cancer-resistant protein inhibitor | 0.439 0.005 CID_174699 | CID_174699 | |
| 0.371 | 0.009 | 0.371 | MAO B inhibitor | |||
| 0.374 | 0.011 | 0.374 | Tyrosine 3 hydroxylase inhibitor | 0.191 0.153 CID_174699 | ||
| 0.364 | 0.006 | 0.364 | Cystathionine beta-synthase inhibitor | |||
| 0.4 | 0.046 | 0.4 | 5 Hydroxytryptamine release stimulant | |||
| 0.361 | 0.008 | 0.361 | Heat shock protein 90 alpha antagonist | |||
| 0.371 | 0.021 | 0.442 | RNA-directed DNA polymerase inhibitor | 0.442 0.014 CID_174699 | CID_174699 | |
| 0.368 | 0.021 | 0.368 | Anesthetic general | |||
| 0.377 | 0.034 | 0.377 | Calcium channel activator | 0.224 0.179 CID_174699 | ||
| 0.343 | 0.006 | 0.343 | Heat shock protein 90 antagonist | |||
| 0.378 | 0.042 | 0.378 | Aryl hydrocarbon receptor agonist | |||
| 0.34 | 0.005 | 0.34 | Nitric-oxide synthase stimulant | 0.186 0.115 CID_174699 | ||
| 0.333 | 0.005 | 0.333 | Farnesoid X receptor antagonist | 0.196 0.023 CID_174699 | ||
| 0.381 | 0.052 | 0.381 | Streptokinase A inhibitor | |||
| 0.425 | 0.1 | 0.425 | Transcription factor inhibitor | |||
| 0.381 | 0.064 | 0.381 | Thioredoxin glutathione reductase inhibitor | |||
| 0.347 | 0.032 | 0.347 | Nitric oxide antagonist | 0.199 0.068 CID_174699 | ||
| 0.317 | 0.005 | 0.317 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.374 | 0.065 | 0.374 | Thyroid hormone antagonist | |||
| 0.366 | 0.058 | 0.461 | Cholesterol antagonist | 0.461 0.039 CID_174699 | CID_174699 | |
| 0.324 | 0.017 | 0.324 | Tubulin antagonist | 0.155 0.056 CID_174699 | ||
| 0.316 | 0.009 | 0.316 | Succinate dehydrogenase inhibitor | 0.199 0.05 CID_174699 | ||
| 0.322 | 0.018 | 0.322 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.317 | 0.017 | 0.317 | Phospholipase C inhibitor | 0.315 0.017 CID_174699 | ||
| 0.308 | 0.01 | 0.308 | 5-Lipoxygenase inhibitor | |||
| 0.348 | 0.057 | 0.348 | Apoptosis antagonist | |||
| 0.355 | 0.067 | 0.355 | Thyroid hormone beta antagonist | |||
| 0.299 | 0.015 | 0.299 | MAO A inhibitor | |||
| 0.3 | 0.02 | 0.3 | Interferon gamma antagonist | |||
| 0.398 | 0.12 | 0.398 | DNA polymerase beta inhibitor | |||
| 0.323 | 0.045 | 0.323 | Hypoglycemic | |||
| 0.298 | 0.028 | 0.298 | DNA methylase inhibitor | |||
| 0.293 | 0.029 | 0.293 | DNA methyltransferase I inhibitor | |||
| 0.284 | 0.021 | 0.284 | Lipid peroxidase inhibitor | 0.174 0.053 CID_174699 | ||
| 0.265 | 0.005 | 0.265 | Macrophage migration inhibitory factor inhibitor | |||
| 0.262 | 0.008 | 0.262 | Beta glucuronidase inhibitor | |||
| 0.267 | 0.014 | 0.267 | Chelator | |||
| 0.378 | 0.125 | 0.378 | DNA directed DNA polymerase inhibitor | |||
| 0.303 | 0.052 | 0.303 | Tumour necrosis factor alpha release inhibitor | 0.162 0.143 CID_174699 | ||
| 0.316 | 0.066 | 0.316 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 CID_174699 | ||
| 0.333 | 0.089 | 0.333 | Prostaglandin dehydrogenase inhibitor | |||
| 0.346 | 0.104 | 0.447 | Antibacterial | 0.447 0.058 CID_174699 | CID_174699 | |
| 0.247 | 0.006 | 0.247 | Photosensitizer | 0.129 0.047 CID_174699 | ||
| 0.26 | 0.021 | 0.26 | Phospholipase A2 inhibitor | 0.195 0.045 CID_174699 | ||
| 0.261 | 0.023 | 0.261 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.303 | 0.069 | 0.303 | Spasmolytic | 0.182 0.135 CID_174699 | ||
| 0.245 | 0.014 | 0.245 | Interleukin 4 antagonist | |||
| 0.248 | 0.019 | 0.248 | Interleukin 1 antagonist | |||
| 0.345 | 0.121 | 0.345 | Calcium channel L-type activator | |||
| 0.229 | 0.007 | 0.229 | HIV-1 integrase (Overall Integration) inhibitor | 0.121 0.039 CID_174699 | ||
| 0.277 | 0.058 | 0.525 | Angiogenesis stimulant | 0.525 0.01 CID_174699 | CID_174699 | |
| 0.245 | 0.028 | 0.245 | Protein kinase stimulant | |||
| 0.241 | 0.024 | 0.241 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.218 | 0.003 | 0.218 | Granulocyte macrophage colony stimulating factor agonist | 0.113 0.021 CID_174699 | ||
| 0.228 | 0.013 | 0.228 | Arachidonic acid antagonist | 0.169 0.067 CID_174699 | ||
| 0.283 | 0.069 | 0.283 | Insulysin inhibitor | |||
| 0.214 | 0.003 | 0.214 | D-Ala-D-Ala ligase inhibitor | 0.084 0.057 CID_174699 | ||
| 0.252 | 0.042 | 0.252 | Non-steroidal antiinflammatory agent | |||
| 0.368 | 0.159 | 0.372 | Antiinflammatory | 0.372 0.157 CID_174699 | CID_174699 | |
| 0.229 | 0.021 | 0.26 | Cholesterol synthesis inhibitor | 0.26 0.016 CID_174699 | CID_174699 | |
| 0.217 | 0.011 | 0.217 | Potassium channel (Ca-activated) activator | |||
| 0.209 | 0.009 | 0.209 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.071 0.06 CID_174699 | ||
| 0.214 | 0.015 | 0.214 | CF transmembrane conductance regulator agonist | |||
| 0.202 | 0.004 | 0.202 | Bile acid receptor antagonist | 0.169 0.005 CID_174699 | ||
| 0.219 | 0.027 | 0.219 | Alkaline phosphatase inhibitor | 0.202 0.032 CID_174699 | ||
| 0.204 | 0.014 | 0.204 | Mediator release inhibitor | |||
| 0.203 | 0.013 | 0.203 | Histidine decarboxylase inhibitor | |||
| 0.206 | 0.017 | 0.206 | UDP-glucose 4-epimerase inhibitor | |||
| 0.196 | 0.007 | 0.196 | DOPA decarboxylase inhibitor | |||
| 0.192 | 0.006 | 0.192 | Leukotriene antagonist | 0.114 0.017 CID_174699 | ||
| 0.204 | 0.018 | 0.204 | Carbonic anhydrase XV inhibitor | 0.112 0.053 CID_174699 | ||
| 0.189 | 0.004 | 0.189 | Ca2+-transporting ATPase inhibitor | 0.141 0.07 CID_174699 | ||
| 0.188 | 0.004 | 0.188 | Potassium channel Kv1.3 blocker | |||
| 0.196 | 0.011 | 0.196 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.299 | 0.115 | 0.299 | Calpain 2 inhibitor | |||
| 0.247 | 0.063 | 0.247 | Interleukin antagonist | |||
| 0.256 | 0.072 | 0.256 | Gastrin inhibitor | |||
| 0.202 | 0.019 | 0.202 | Interleukin 1b antagonist | |||
| 0.207 | 0.025 | 0.207 | GABA C receptor rho-2 antagonist | |||
| 0.199 | 0.019 | 0.199 | Xanthine oxidase inhibitor | |||
| 0.186 | 0.01 | 0.186 | Keratolytic | |||
| 0.2 | 0.024 | 0.2 | Toll-Like receptor 2 antagonist | |||
| 0.191 | 0.015 | 0.191 | Mucolytic | 0.092 0.09 CID_174699 | ||
| 0.206 | 0.032 | 0.206 | Hexokinase inhibitor | |||
| 0.25 | 0.075 | 0.25 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.204 | 0.031 | 0.204 | Anesthetic local | |||
| 0.204 | 0.033 | 0.204 | Cyclooxygenase 1 inhibitor | 0.196 0.036 CID_174699 | ||
| 0.236 | 0.066 | 0.236 | Antimitotic | 0.187 0.092 CID_174699 | ||
| 0.242 | 0.073 | 0.242 | Calpain inhibitor | |||
| 0.197 | 0.028 | 0.197 | Aldehyde dehydrogenase inhibitor | |||
| 0.185 | 0.017 | 0.185 | Vanilloid 1 agonist | 0.149 0.04 CID_174699 | ||
| 0.205 | 0.045 | 0.377 | Protein-tyrosine phosphatase inhibitor | 0.377 0.01 CID_174699 | CID_174699 | |
| 0.216 | 0.056 | 0.243 | Hepatoprotectant | 0.243 0.045 CID_174699 | CID_174699 | |
| 0.189 | 0.033 | 0.189 | Neurotrophic factor | |||
| 0.173 | 0.017 | 0.173 | Estrogen antagonist | |||
| 0.16 | 0.005 | 0.16 | Leukotriene B4 antagonist | 0.132 0.006 CID_174699 | ||
| 0.207 | 0.052 | 0.207 | Mcl-1 antagonist | |||
| 0.179 | 0.025 | 0.179 | Expectorant | |||
| 0.209 | 0.056 | 0.433 | Dual specificity phosphatase 3 inhibitor | 0.433 0.011 CID_174699 | CID_174699 | |
| 0.157 | 0.004 | 0.157 | Leukotriene D4 antagonist | 0.023 0.021 CID_174699 | ||
| 0.189 | 0.037 | 0.189 | Acetylcholinesterase inhibitor | |||
| 0.169 | 0.017 | 0.169 | Creatine kinase inhibitor | |||
| 0.156 | 0.006 | 0.156 | Purinergic P2X1 antagonist | 0.066 0.035 CID_174699 | ||
| 0.161 | 0.011 | 0.161 | Beta tubulin antagonist | |||
| 0.154 | 0.006 | 0.154 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.165 | 0.019 | 0.325 | Carbonic anhydrase XIII inhibitor | 0.325 0.005 CID_174699 | CID_174699 | |
| 0.169 | 0.023 | 0.169 | Carbonic anhydrase III inhibitor | 0.113 0.05 CID_174699 | ||
| 0.15 | 0.005 | 0.15 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.06 0.03 CID_174699 | ||
| 0.175 | 0.03 | 0.175 | Cyclooxygenase 3 inhibitor | |||
| 0.234 | 0.091 | 0.234 | Interleukin agonist | |||
| 0.152 | 0.01 | 0.152 | Ornithine decarboxylase inhibitor | |||
| 0.208 | 0.067 | 0.447 | Platelet adhesion inhibitor | 0.447 0.008 CID_174699 | CID_174699 | |
| 0.167 | 0.03 | 0.167 | Microtubule formation inhibitor | |||
| 0.205 | 0.068 | 0.205 | Insulin sensitizer | |||
| 0.151 | 0.015 | 0.151 | Estrogen receptor beta antagonist | |||
| 0.14 | 0.005 | 0.14 | GABA B receptor agonist | 0.083 0.036 CID_174699 | ||
| 0.143 | 0.008 | 0.143 | Glycine receptor agonist | 0.074 0.047 CID_174699 | ||
| 0.193 | 0.059 | 0.436 | Dual specificity phosphatase inhibitor | 0.436 0.011 CID_174699 | CID_174699 | |
| 0.17 | 0.038 | 0.237 | Protein-tyrosine phosphatase 1B inhibitor | 0.237 0.019 CID_174699 | CID_174699 | |
| 0.159 | 0.029 | 0.159 | Heat shock protein 70 antagonist | |||
| 0.219 | 0.09 | 0.219 | Vasodilator | |||
| 0.151 | 0.022 | 0.151 | Androgen antagonist | |||
| 0.198 | 0.072 | 0.198 | Histone acetyltransferase inhibitor | |||
| 0.149 | 0.023 | 0.149 | Phosphodiesterase IV inhibitor | |||
| 0.178 | 0.052 | 0.178 | Neurotensin receptor agonist | |||
| 0.139 | 0.014 | 0.323 | HIV-1 integrase (Strand Transfer) inhibitor | 0.323 0.005 CID_174699 | CID_174699 | |
| 0.158 | 0.033 | 0.158 | Falcipain 3 inhibitor | |||
| 0.136 | 0.012 | 0.136 | Alcohol oxidase inhibitor | |||
| 0.165 | 0.041 | 0.165 | Adenylate cyclase stimulant | 0.142 0.076 CID_174699 | ||
| 0.129 | 0.007 | 0.129 | Estrogen-related receptor beta agonist | |||
| 0.149 | 0.027 | 0.149 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.166 | 0.045 | 0.166 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.143 | 0.022 | 0.143 | Porphobilinogen synthase inhibitor | |||
| 0.22 | 0.1 | 0.22 | DNA damaging | |||
| 0.145 | 0.026 | 0.145 | Urease inhibitor | |||
| 0.15 | 0.031 | 0.15 | TRPA1 agonist | 0.121 0.058 CID_174699 | ||
| 0.184 | 0.067 | 0.184 | Lipocortins synthesis antagonist | |||
| 0.131 | 0.015 | 0.131 | Estrogen receptor alpha antagonist | |||
| 0.16 | 0.045 | 0.16 | Topoisomerase II inhibitor | |||
| 0.156 | 0.041 | 0.156 | Antibacterial (Helicobacter pylori) | 0.12 0.081 CID_174699 | ||
| 0.124 | 0.01 | 0.124 | Xanthine dehydrogenase inhibitor | |||
| 0.129 | 0.017 | 0.281 | HIV-1 integrase (3'-Processing) inhibitor | 0.281 0.005 CID_174699 | CID_174699 | |
| 0.213 | 0.104 | 0.213 | DNA synthesis inhibitor | |||
| 0.137 | 0.029 | 0.137 | Electron transport complex I inhibitor | |||
| 0.166 | 0.059 | 0.166 | Cyclooxygenase inhibitor | 0.114 0.107 CID_174699 | ||
| 0.121 | 0.015 | 0.125 | HIV-1 integrase inhibitor | 0.125 0.014 CID_174699 | CID_174699 | |
| 0.129 | 0.024 | 0.129 | NADH dehydrogenase inhibitor | 0.08 0.075 CID_174699 | ||
| 0.199 | 0.094 | 0.199 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.117 | 0.013 | 0.117 | Alpha tubulin antagonist | |||
| 0.137 | 0.035 | 0.137 | Transcription factor STAT6 inhibitor | |||
| 0.13 | 0.029 | 0.13 | Alcohol dehydrogenase inhibitor | |||
| 0.128 | 0.028 | 0.128 | Topoisomerase II alpha inhibitor | |||
| 0.167 | 0.067 | 0.167 | Interleukin 6 antagonist | |||
| 0.121 | 0.021 | 0.121 | Glutamate release inhibitor | |||
| 0.12 | 0.021 | 0.12 | Glutamate decarboxylase inhibitor | |||
| 0.13 | 0.031 | 0.142 | Anabolic | 0.142 0.022 CID_174699 | CID_174699 | |
| 0.115 | 0.019 | 0.115 | Leukotriene synthesis inhibitor | |||
| 0.115 | 0.018 | 0.115 | Potassium channel large-conductance Ca-activated activator | |||
| 0.13 | 0.034 | 0.182 | Acetylcholine release stimulant | 0.182 0.005 CID_174699 | CID_174699 | |
| 0.105 | 0.009 | 0.105 | Heat shock protein 90 beta antagonist | |||
| 0.13 | 0.035 | 0.13 | Sphingomyelinase inhibitor | |||
| 0.089 | 0.005 | 0.089 | Ryanodine receptor antagonist | |||
| 0.091 | 0.01 | 0.091 | Transcription factor RelA inhibitor | |||
| 0.098 | 0.017 | 0.098 | Beta adrenoreceptor antagonist | |||
| 0.132 | 0.052 | 0.132 | DNA repair enzyme inhibitor | |||
| 0.085 | 0.006 | 0.085 | Leukotriene C antagonist | |||
| 0.135 | 0.056 | 0.135 | Alkylator | 0.111 0.077 CID_174699 | ||
| 0.281 | 0.202 | 0.281 | MAP kinase 1 inhibitor | |||
| 0.138 | 0.059 | 0.138 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.082 | 0.004 | 0.082 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.118 | 0.04 | 0.118 | Prolactin inhibitor | |||
| 0.091 | 0.013 | 0.091 | Phosphodiesterase 1C inhibitor | |||
| 0.145 | 0.069 | 0.145 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.12 | 0.044 | 0.12 | Toll-Like receptor 4 antagonist | |||
| 0.108 | 0.034 | 0.108 | Phosphodiesterase 4D inhibitor | |||
| 0.077 | 0.004 | 0.077 | Leukotriene B4 receptor 1 antagonist | |||
| 0.119 | 0.047 | 0.119 | Butyrylcholinesterase inhibitor | |||
| 0.159 | 0.087 | 0.159 | ATPase inhibitor | |||
| 0.116 | 0.044 | 0.116 | GABA C receptor rho-1 antagonist | |||
| 0.148 | 0.077 | 0.148 | Cytidine deaminase inhibitor | |||
| 0.125 | 0.053 | 0.125 | Caspase 3 inhibitor | |||
| 0.132 | 0.061 | 0.132 | Cathepsin H inhibitor | |||
| 0.089 | 0.018 | 0.089 | Glutamate (mGluR7) antagonist | |||
| 0.091 | 0.02 | 0.091 | Potassium channel (ATP-sensitive) blocker | |||
| 0.16 | 0.09 | 0.16 | Amyloid beta precursor protein antagonist | |||
| 0.098 | 0.028 | 0.098 | Phosphodiesterase 5A inhibitor | |||
| 0.083 | 0.016 | 0.083 | Beta 1 adrenoreceptor antagonist | |||
| 0.12 | 0.053 | 0.12 | GABA C receptor antagonist | |||
| 0.115 | 0.048 | 0.115 | Bronchodilator | |||
| 0.077 | 0.012 | 0.077 | Dihydroorotate oxidase inhibitor | |||
| 0.145 | 0.082 | 0.548 | Diuretic | 0.548 0.005 CID_174699 | CID_174699 | |
| 0.084 | 0.022 | 0.223 | Estrogen agonist | 0.223 0.007 CID_174699 | CID_174699 | |
| 0.08 | 0.018 | 0.08 | Cyclin D1 inhibitor | |||
| 0.124 | 0.062 | 0.124 | Proteasome inhibitor | |||
| 0.103 | 0.041 | 0.103 | Phosphodiesterase I inhibitor | |||
| 0.084 | 0.023 | 0.084 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.093 | 0.031 | 0.093 | Phosphodiesterase V inhibitor | |||
| 0.099 | 0.039 | 0.099 | Glutathione S-transferase inhibitor | |||
| 0.092 | 0.032 | 0.092 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.09 | 0.03 | 0.177 | Carbonic anhydrase VA inhibitor | 0.177 0.007 CID_174699 | CID_174699 | |
| 0.081 | 0.022 | 0.081 | Phosphodiesterase 1B inhibitor | |||
| 0.082 | 0.023 | 0.082 | Aldose reductase inhibitor | 0.074 0.026 CID_174699 | ||
| 0.073 | 0.014 | 0.073 | Glucose-6-phosphate translocase inhibitor | |||
| 0.065 | 0.005 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.072 | 0.014 | 0.106 | Adenine nucleotide translocase inhibitor | 0.106 0.004 CID_174699 | CID_174699 | |
| 0.11 | 0.053 | 0.214 | Gastric antisecretory | 0.214 0.01 CID_174699 | CID_174699 | |
| 0.102 | 0.046 | 0.256 | Triose-phosphate isomerase inhibitor | 0.256 0.006 CID_174699 | CID_174699 | |
| 0.111 | 0.056 | 0.111 | GABA C receptor agonist | |||
| 0.095 | 0.041 | 0.095 | Myeloperoxidase inhibitor | |||
| 0.089 | 0.035 | 0.089 | Lipase inhibitor | |||
| 0.086 | 0.033 | 0.239 | Carbonic anhydrase V inhibitor | 0.239 0.005 CID_174699 | CID_174699 | |
| 0.089 | 0.036 | 0.089 | Phosphofructokinase-1 inhibitor | |||
| 0.08 | 0.027 | 0.08 | Aromatase inhibitor | |||
| 0.059 | 0.006 | 0.059 | Leukotriene C4 antagonist | |||
| 0.085 | 0.033 | 0.085 | MAP kinase kinase 7 inhibitor | |||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | |||
| 0.182 | 0.132 | 0.242 | Immunostimulant | 0.242 0.1 CID_174699 | CID_174699 | |
| 0.093 | 0.044 | 0.093 | Inducible nitric-oxide synthase inhibitor | 0.085 0.055 CID_174699 | ||
| 0.067 | 0.018 | 0.067 | Pregnane X receptor antagonist | |||
| 0.284 | 0.236 | 0.284 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.075 | 0.027 | 0.075 | Beta 3 adrenoreceptor antagonist | |||
| 0.108 | 0.061 | 0.108 | AMP-activated protein kinase stimulant | |||
| 0.073 | 0.027 | 0.073 | Transcription factor AP-1 inhibitor | |||
| 0.085 | 0.039 | 0.085 | Histone deacetylase stimulant | |||
| 0.085 | 0.039 | 0.085 | Histone deacetylase SIRT1 stimulant | |||
| 0.094 | 0.049 | 0.094 | Antineoplastic antibiotic | 0.075 0.061 CID_174699 | ||
| 0.088 | 0.043 | 0.088 | Thioredoxin reductase inhibitor | |||
| 0.085 | 0.04 | 0.085 | GABA aminotransferase inhibitor | |||
| 0.105 | 0.06 | 0.105 | Adenylate kinase inhibitor | |||
| 0.088 | 0.043 | 0.094 | Na+ K+ transporting ATPase inhibitor | 0.094 0.038 CID_174699 | CID_174699 | |
| 0.075 | 0.031 | 0.075 | Aryl hydrocarbon receptor antagonist | |||
| 0.056 | 0.013 | 0.056 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.057 | 0.014 | 0.061 | Guanylate cyclase inhibitor | 0.061 0.011 CID_174699 | CID_174699 | |
| 0.089 | 0.047 | 0.089 | Carbonic anhydrase VI inhibitor | 0.073 0.067 CID_174699 | ||
| 0.052 | 0.01 | 0.052 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.066 | 0.024 | 0.066 | 5 Hydroxytryptamine 7 agonist | |||
| 0.057 | 0.015 | 0.057 | Estrogen receptor alpha agonist | |||
| 0.073 | 0.031 | 0.115 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CID_174699 | CID_174699 | |
| 0.067 | 0.026 | 0.067 | Beta 2 adrenoreceptor agonist | |||
| 0.044 | 0.005 | 0.044 | Leukotriene B4 receptor 2 antagonist | |||
| 0.053 | 0.014 | 0.053 | GABA uptake inhibitor | |||
| 0.207 | 0.168 | 0.354 | Antithrombotic | 0.354 0.063 CID_174699 | CID_174699 | |
| 0.092 | 0.054 | 0.092 | Calcium antagonist | |||
| 0.097 | 0.059 | 0.097 | Phosphodiesterase 6D inhibitor | |||
| 0.044 | 0.007 | 0.044 | Glutamate (mGluR3) agonist | |||
| 0.131 | 0.095 | 0.131 | Cholinergic | |||
| 0.06 | 0.025 | 0.06 | Carbonic anhydrase XIV inhibitor | |||
| 0.078 | 0.044 | 0.078 | Phosphodiesterase VI inhibitor | |||
| 0.068 | 0.033 | 0.068 | Calcium channel P-type blocker | |||
| 0.102 | 0.068 | 0.102 | Topoisomerase I inhibitor | |||
| 0.115 | 0.081 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.147 | 0.114 | 0.147 | Catenin beta inhibitor | |||
| 0.116 | 0.084 | 0.116 | Cyclooxygenase 2 inhibitor | 0.111 0.09 CID_174699 | ||
| 0.037 | 0.006 | 0.037 | Prostaglandin F2 alpha agonist | |||
| 0.063 | 0.033 | 0.063 | Maillard reaction inhibitor | |||
| 0.068 | 0.039 | 0.081 | Protease 3C (Human rhinovirus) inhibitor | 0.081 0.026 CID_174699 | CID_174699 | |
| 0.096 | 0.067 | 0.096 | Glutamate (mGluR7) agonist | |||
| 0.129 | 0.1 | 0.129 | NOS3 expression enhancer | |||
| 0.038 | 0.009 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.074 | 0.046 | 0.074 | Calcium channel L-type blocker | |||
| 0.044 | 0.015 | 0.044 | Sirtuin 2 inhibitor | |||
| 0.082 | 0.054 | 0.122 | Glycine receptor antagonist | 0.122 0.017 CID_174699 | CID_174699 | |
| 0.045 | 0.018 | 0.045 | Glutamate (mGluR group II) agonist | |||
| 0.075 | 0.048 | 0.191 | Cathepsin G inhibitor | 0.191 0.017 CID_174699 | CID_174699 | |
| 0.054 | 0.027 | 0.054 | CD45 antagonist | |||
| 0.046 | 0.02 | 0.046 | Dihydropteroate synthase inhibitor | |||
| 0.084 | 0.058 | 0.084 | Vanilloid agonist | |||
| 0.03 | 0.004 | 0.03 | Antibiotic Anthracycline-like | |||
| 0.035 | 0.009 | 0.035 | Estrogen-related receptor gamma antagonist | |||
| 0.046 | 0.021 | 0.046 | Dopamine D5 agonist | |||
| 0.07 | 0.045 | 0.07 | Purinergic P2X2 antagonist | |||
| 0.041 | 0.017 | 0.041 | Glutamate (mGluR2) agonist | |||
| 0.072 | 0.048 | 0.072 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.066 | 0.043 | 0.066 | Dopamine D1 antagonist | |||
| 0.045 | 0.023 | 0.045 | Heme oxygenase inhibitor | |||
| 0.062 | 0.04 | 0.062 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.104 | 0.082 | 0.104 | DNA polymerase I inhibitor | |||
| 0.062 | 0.041 | 0.076 | Neuraminidase inhibitor | 0.076 0.028 CID_174699 | CID_174699 | |
| 0.059 | 0.038 | 0.059 | Lipocortins synthesis agonist | |||
| 0.031 | 0.01 | 0.031 | Sodium/glucose cotransporter inhibitor | |||
| 0.041 | 0.021 | 0.041 | Glutamate (mGluR8) agonist | |||
| 0.051 | 0.031 | 0.051 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.083 | 0.063 | 0.083 | Histamine N-methyltransferase inhibitor | |||
| 0.132 | 0.112 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.052 | 0.033 | 0.052 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.085 | 0.066 | 0.085 | ATPase (Vacuolar H+) inhibitor | |||
| 0.051 | 0.033 | 0.051 | Squalene epoxidase inhibitor | |||
| 0.04 | 0.021 | 0.109 | Estrogen receptor beta agonist | 0.109 0.01 CID_174699 | CID_174699 | |
| 0.049 | 0.031 | 0.049 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.054 | 0.036 | 0.062 | Alpha-mannosidase inhibitor | 0.062 0.024 CID_174699 | CID_174699 | |
| 0.067 | 0.049 | 0.067 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | |||
| 0.04 | 0.023 | 0.04 | Retinoid X receptor antagonist | |||
| 0.052 | 0.036 | 0.052 | Vanilloid 2 antagonist | |||
| 0.044 | 0.027 | 0.044 | DNA gyrase subunit A inhibitor | |||
| 0.066 | 0.049 | 0.066 | Glutamate (mGluR6) antagonist | |||
| 0.048 | 0.032 | 0.048 | Glycine transporter 2 inhibitor | |||
| 0.042 | 0.027 | 0.042 | Kainate receptor agonist | |||
| 0.035 | 0.02 | 0.035 | Melatonin receptor 1A agonist | |||
| 0.07 | 0.056 | 0.193 | CDC25A inhibitor | 0.193 0.007 CID_174699 | CID_174699 | |
| 0.041 | 0.028 | 0.041 | Plasmepsin II inhibitor | |||
| 0.037 | 0.024 | 0.037 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Hedgehog signaling activator | |||
| 0.065 | 0.053 | 0.065 | Elastase 1 inhibitor | |||
| 0.067 | 0.054 | 0.067 | Amidase inhibitor | |||
| 0.053 | 0.042 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.085 | 0.074 | 0.085 | Uric acid excretion stimulant | |||
| 0.045 | 0.034 | 0.045 | Carbonic anhydrase VII inhibitor | |||
| 0.035 | 0.024 | 0.035 | Phosphoglycerate kinase inhibitor | 0.033 0.027 CID_174699 | ||
| 0.034 | 0.024 | 0.034 | Retinoid X alpha receptor antagonist | |||
| 0.014 | 0.004 | 0.014 | Progesterone receptor A antagonist | |||
| 0.029 | 0.019 | 0.029 | Uridine phosphorylase inhibitor | |||
| 0.053 | 0.043 | 0.053 | Argininosuccinate synthase inhibitor | |||
| 0.04 | 0.03 | 0.04 | Liver X receptor alpha agonist | |||
| 0.14 | 0.131 | 0.14 | I kappa B kinase epsilon inhibitor | |||
| 0.049 | 0.04 | 0.049 | Aconitate hydratase inhibitor | |||
| 0.077 | 0.068 | 0.077 | Caspase 7 inhibitor | |||
| 0.05 | 0.042 | 0.05 | Alpha 1L adrenoreceptor antagonist | |||
| 0.037 | 0.029 | 0.037 | Urate transporter 1 inhibitor | |||
| 0.034 | 0.026 | 0.034 | Progesterone antagonist | |||
| 0.09 | 0.083 | 0.09 | Ferrochelatase inhibitor | |||
| 0.032 | 0.024 | 0.032 | Estrogen-related receptor beta antagonist | |||
| 0.045 | 0.038 | 0.045 | Benzodiazepine antagonist | |||
| 0.079 | 0.072 | 0.079 | mTOR complex 2 inhibitor | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.065 | 0.059 | 0.128 | Catalase inhibitor | 0.128 0.031 CID_174699 | CID_174699 | |
| 0.048 | 0.041 | 0.13 | Factor IXa inhibitor | 0.13 0.005 CID_174699 | CID_174699 | |
| 0.013 | 0.007 | 0.013 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.082 | 0.077 | 0.082 | Thioredoxin inhibitor | |||
| 0.019 | 0.014 | 0.019 | Progesterone receptor B antagonist | |||
| 0.047 | 0.041 | 0.047 | Beta 2 adrenoreceptor antagonist | |||
| 0.053 | 0.047 | 0.053 | Immunoglobulin Fc receptor antagonist | |||
| 0.014 | 0.009 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.046 | 0.041 | 0.046 | Topoisomerase II beta inhibitor | |||
| 0.05 | 0.046 | 0.074 | Heparanase inhibitor | 0.074 0.009 CID_174699 | CID_174699 | |
| 0.051 | 0.047 | 0.051 | DNA helicase inhibitor | |||
| 0.035 | 0.032 | 0.035 | Potassium channel Kv1.1 blocker | |||
| 0.066 | 0.063 | 0.066 | Glutamate dehydrogenase inhibitor | |||
| 0.03 | 0.027 | 0.03 | Catechol O-methyltransferase inhibitor | |||
| 0.042 | 0.039 | 0.042 | Adenylate cyclase 1 inhibitor | |||
| 0.057 | 0.055 | 0.057 | Heme oxygenase stimulant | |||
| 0.033 | 0.031 | 0.033 | 5-Alpha-reductase inhibitor | |||
| 0.085 | 0.084 | 0.085 | Electrolyte absorption antagonist | |||
| 0.034 | 0.033 | 0.034 | Glutamate (mGluR group II) antagonist | |||
| 0.121 | 0.12 | 0.121 | Growth hormone agonist | |||
| 0.071 | 0.07 | 0.071 | Adrenaline agonist | |||
| 0.024 | 0.023 | 0.024 | Thyroid hormone agonist | |||
| 0.031 | 0.03 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.043 | 0.042 | 0.043 | Aldosterone antagonist | |||
| 0.04 | 0.04 | 0.056 | Dihydrofolate reductase inhibitor | 0.056 0.013 CID_174699 | CID_174699 | |
| 0.037 | 0.038 | 0.185 | Leukocyte elastase inhibitor | 0.185 0.005 CID_174699 | CID_174699 | |
| 0.039 | 0.042 | 0.049 | Mannosidase inhibitor | 0.049 0.027 CID_174699 | CID_174699 | |
| 0.08 | 0.086 | 0.102 | Protein kinase C zeta inhibitor | 0.102 0.048 CID_174699 | CID_174699 | |
| 0.182 | 0.191 | 0.61 | Angiogenesis inhibitor | 0.61 0.015 CID_174699 | CID_174699 | |
| 0.04 | 0.051 | 0.063 | Carbonic anhydrase IX inhibitor | 0.063 0.036 CID_174699 | CID_174699 | |
| 0.047 | 0.059 | 0.155 | Carbonic anhydrase inhibitor | 0.155 0.015 CID_174699 | CID_174699 | |
| 0.184 | 0.196 | 0.422 | Beta lactamase inhibitor | 0.422 0.093 CID_174699 | CID_174699 | |
| 0.108 | 0.12 | 0.221 | Cell wall synthesis inhibitor | 0.221 0.023 CID_174699 | CID_174699 | |
| 0.049 | 0.066 | 0.067 | Sphingosine kinase inhibitor | 0.067 0.028 CID_174699 | CID_174699 | |
| 0.069 | 0.095 | 0.115 | Aminopeptidase B inhibitor | 0.115 0.055 CID_174699 | CID_174699 | |
| 0.032 | 0.067 | 0.079 | Carbonic anhydrase VB inhibitor | 0.079 0.023 CID_174699 | CID_174699 | |
| 0.012 | 0.051 | 0.028 | Kynurenine 3 monooxygenase inhibitor | 0.028 0.017 CID_174699 | CID_174699 | |
| 0.034 | 0.075 | 0.113 | H+/K+-transporting ATPase inhibitor | 0.113 0.007 CID_174699 | CID_174699 | |
| 0.077 | 0.128 | 0.262 | Multidrug resistance-associated protein 1 inhibitor | 0.262 0.005 CID_174699 | CID_174699 | |
| 0.008 | 0.059 | 0.126 | Estrone sulfatase inhibitor | 0.126 0.004 CID_174699 | CID_174699 | |
| 0.011 | 0.065 | 0.025 | Glutamate (mGluR1a) agonist | 0.025 0.012 CID_174699 | CID_174699 | |
| 0.019 | 0.078 | 0.038 | Toll-Like receptor 4 agonist | 0.038 0.005 CID_174699 | CID_174699 | |
| 0.012 | 0.122 | 0.09 | NMDA 2D receptor antagonist | 0.09 0.004 CID_174699 | CID_174699 | |
| 0.021 | 0.155 | 0.11 | Elastase inhibitor | 0.11 0.008 CID_174699 | CID_174699 | |
| 0.01 | 0.148 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.004 CID_174699 | CID_174699 | |
| 0.021 | 0.175 | 0.204 | Selectin antagonist | 0.204 0.011 CID_174699 | CID_174699 | |
| 0.079 | 0.254 | 0.248 | Hemostatic | 0.248 0.022 CID_174699 | CID_174699 | |
| 0.007 | 0.215 | 0.041 | Dopamine D2 agonist | 0.041 0.034 CID_174699 | CID_174699 | |
| 0.008 | 0.222 | 0.044 | Factor Xa inhibitor | 0.044 0.034 CID_174699 | CID_174699 | |
| 0.04 | 0.28 | 0.142 | Thrombolytic | 0.142 0.088 CID_174699 | CID_174699 | |
| 0.004 | 0.269 | 0.791 | Cholecystokinin A agonist | 0.791 0.001 CID_174699 | CID_174699 | |
| 0.004 | 0.314 | 0.792 | Cholecystokinin agonist | 0.792 0.001 CID_174699 | CID_174699 | |
| 0.012 | 0.347 | 0.038 | Purinergic P2Y2 antagonist | 0.038 0.018 CID_174699 | CID_174699 | |
| 0.005 | 0.473 | 0.23 | NMDA 2B receptor antagonist | 0.23 0.005 CID_174699 | CID_174699 | |
| 0.01 | 0.515 | 0.717 | Cholecystokinin B agonist | 0.717 0.001 CID_174699 | CID_174699 | |
| 0.023 | 0.571 | 0.102 | Nav1.4 sodium channel blocker | 0.102 0.072 CID_174699 | CID_174699 | |
| 0.004 | 0.571 | 0.033 | Factor XI inhibitor | 0.033 0.024 CID_174699 | CID_174699 | |
| 0.003 | 0.588 | 0.365 | Cholecystokinin A antagonist | 0.365 0.003 CID_174699 | CID_174699 | |
| 0.009 | 0.6 | 0.077 | Thrombin inhibitor | 0.077 0.045 CID_174699 | CID_174699 | |
| 0.011 | 0.673 | 0.428 | Anticoagulant | 0.428 0.014 CID_174699 | CID_174699 | |
| 0.003 | 0.69 | 0.289 | Cholecystokinin antagonist | 0.289 0.004 CID_174699 | CID_174699 | |
| 0.003 | 0.724 | 0.262 | Cholecystokinin B antagonist | 0.262 0.004 CID_174699 | CID_174699 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |